Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
British Journal of Pharmacology|July 4, 2003
Various intracellular compartments cooperate in the release of nitric oxide from glycerol trinitrate in liverAndrey V Kozlov, Barbara Dietrich, Hans Nohl
Biofactors (Oxford, England)|February 6, 2004
Caroverine, a multifunctional drug with antioxidant functionsHans Nohl, Werner Bieberschulte, Barbara Dietrich, et al.
Toxicology and Applied Pharmacology|June 23, 2009
A note on statistical analysis of organ weights in non-clinical toxicological studiesMartin J Wolfsegger, Thomas Jaki, Barbara Dietrich, et al.
Toxicology and Applied Pharmacology|May 1, 2021
Co-administration of CSL112 (apolipoprotein A-I [human]) with atorvastatin and alirocumab is not associated with increased hepatotoxic or toxicokinetic effects in ratsAndrea Beyerle, Brandon Greene, Barbara Dietrich, et al.
Blood|April 25, 2012
A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13Alexandra Schiviz, Kuno Wuersch, Christina Piskernik, et al.
Frontiers in Endocrinology|August 5, 2017
Thyroid Allostasis-Adaptive Responses of Thyrotropic Feedback Control to Conditions of Strain, Stress, and Developmental ProgrammingApostolos Chatzitomaris, Rudolf Hoermann, John E Midgley, et al.
Seminars in Thrombosis and Hemostasis|July 16, 2010
Preclinical testing of human recombinant von Willebrand factor: ADAMTS13 cleavage capacity in animals as criterion for species suitabilityEva-Maria Muchitsch, Barbara Dietrich, Hanspeter Rottensteiner, et al.
International Journal of Hematology|September 25, 2013
Preclinical safety and efficacy of a new recombinant FIX drug product for treatment of hemophilia BBarbara Dietrich, Alexandra Schiviz, Werner Hoellriegl, et al.
Blood|August 24, 2012
Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in miceSimon F De Meyer, Alexander S Savchenko, Michael S Haas, et al.
Toxicology and Applied Pharmacology|December 8, 2024
Preclinical safety and efficacy of the recombinant CR1 drug product CSL040 in rats and cynomolgus monkeysTanja Ruthsatz, Sandra Wymann, Elena Velkoska, et al.
Pageof 2